Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bone Neoplasms × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 9 Pain 5 Breast Neoplasms 5 Neuralgia 4 Agnosia 4 Neoplasms 2 Head and Neck Neoplasms 2 Chronic Pain 2 Visceral Pain 1 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Persistent Postoperative Pain 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Myotoxicity 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Leiomyoma 1 Inflammation 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1

Interventions

Ibandronic Acid 8 Gemcitabine 7 Doxorubicin 6 Cyclophosphamide 5 Radiation 4 Nivolumab 4 Irinotecan 4 pembrolizumab 3 Zoledronic Acid 3 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Methotrexate 2 Injections 2 Ifosfamide 2 Etoposide 2 Denosumab 2 Cryotherapy 2 Cryosurgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡